Fluoroestradiol (18F) 2026
Original notice title
Czechia – Radioactive materials – Fluoroestradiol (18F) 2026
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
40 / 100
Risk factors
Short submission period (35 days) may be insufficient for preparing required documents.
Eligibility criteria are not disclosed in the notice – bidders must access procurement documents to understand requirem...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Fakultní nemocnice Olomouc
- Country
- Czech Republic
- CPV
- 09343000 - Radioactive materials +1 more
- Deadline
- Jul 07, 2026
- Estimated value
- CZK 5.4M (approx. EUR 223k)
Overview
Moderate opportunityKey Facts
- CZK 5.4M estimated value
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Repeated supplies of medicinal products containing fluoroestradiol (18F)
Show full summary
Open tender for repeated supplies of medicinal products containing fluoroestradiol (18F) for Fakultní nemocnice Olomouc in Czechia. Single lot, 36-month contract, award based on lowest price.
Risks
Short submission period (35 days) may be insufficient for preparing required documents.
Eligibility criteria are not disclosed in the notice – bidders must access procurement documents to understand requirem...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Delivery to Olomouc region (CZ071), Czechia
- Contract duration 36 months
Administrative
- Electronic submission required
Award Criteria
Lot 1
Buyer
Location
Olomouc - Nová Ulice, CZE
Website
Buyer profile
Identifier
00098892
Activity
Health
Lots (1)
LOT-0001
Fluoroestradiol (18F) 2026
Repeated deliveries of medicinal products with active substance fluoroestradiol (18F). Estimated value 5,415,552 CZK, duration 36 months.
EUR 223k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Zadavatel bude hodnotit v souladu s § 114 odst. 2 ZZVZ ekonomickou výhodnost nabídek podle nejnižší nabídkové ceny v Kč bez DPH, která bude převzata z vyplněného krycího listu nabídkové ceny. V případě rovnosti nejnižších celkových nabídkových cen v Kč bez DPH několika účastníků rozhodne o výběru nejvýhodnější nabídky los. Účastníci, kteří podali shodnou nejnižší celkovou nabídkovou cenu, budou zadavatelem písemně vyzváni k osobní účasti na losování. Hodnotící komise posoudí nabídky podle ust. § 113 ZZVZ (mimořádně nízká nabídková cena).
Additional CPV codes
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky Fluoroestradiol (18F)
Procurement Details
- Publication date
- 02 Jun 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 380529-2026
Documents (1)
Similar tenders
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
40 / 100
Risk factors
Short submission period (35 days) may be insufficient for preparing required documents.
Eligibility criteria are not disclosed in the notice – bidders must access procurement documents to understand requirem...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications